Singular Health GroupASX:SHG 30 3-Year ROIIC % is 165.02 as of Jun. 2025, which is 18% above its 10-year median of 139.45. GuruFocus rates ASX:SHG with a GF Score™ of 30/100 and a GF Value™ of A$0.11 (Significantly Overvalued). The stock has 2 warning signs investors should review. Among 620 Healthcare Providers & Services companies, Singular Health Group ranks better than 92.42% on this metric.
3-Year Return on Invested Incremental Capital (3-Year ROIIC %) measures the change in earnings as a percentage of change in investment over 3-year.
Singular Health Group's 3-Year ROIIC % for the quarter that ended in Jun. 2025 was 165.02%. High ROIIC is generally an indication that your business is capital efficient or has a higher operating leverage.
The industry rank for Singular Health Group's 3-Year ROIIC % or its related term are showing as below:
ASX:SHG's 3-Year ROIIC % is ranked better than 92.42% of 620
companies
in the Healthcare Providers & Services industry
Industry Median: 3.28
vs ASX:SHG: 165.02
Singular Health Group (ASX:SHG) 3-Year ROIIC % Explanation
Return on Incremental Invested Capital (ROIIC) is an extension of Return on Investment Capital (ROIC). ROIC % tells investors how efficiently that profitability is earned per dollar of company capital. ROIIC narrows the focus even further and shows how profitable each additional unit of capital investment could be. ROIIC % is a more powerful metric than ROIC because it measures how much money the company can generate going forward on future capital investments.
High ROIIC is generally an indication that your business is capital efficient or has a higher operating leverage.
Be Aware
It's important to keep in mind that when tracking ROIIC, the metric is better suited to forecasting the trend of future returns rather than measuring current return on investment.
Singular Health Group 3-Year ROIIC % Related Terms
Singular Health Group 3-Year ROIIC % Historical Data
* Premium members only.
The historical data trend for Singular Health Group's 3-Year ROIIC % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
ASX:SHG vs VEEV, BTSG, TEM: 3-Year ROIIC % Comparison
For the Health Information Services subindustry, Singular Health Group's 3-Year ROIIC %, along with its competitors' market caps and 3-Year ROIIC % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Singular Health Group 3-Year ROIIC % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Singular Health Group's 3-Year ROIIC % distribution charts can be found below:
* The bar in red indicates where Singular Health Group's 3-Year ROIIC % falls into.
Singular Health Group's 3-Year ROIIC % for the quarter that ended in Jun. 2025 is calculated as:
3-Year ROIIC %
=
3-Year Incremental Net Operating Profit After Taxes (NOPAT)**
/
3-Year Incremental Invested Capital**
=
( -6.751 (Jun. 2025) - -6.284 (Jun. 2022) )
/
( 0.7 (Jun. 2025) - 0.983 (Jun. 2022) )
=
-0.467
/
-0.283
=
165.02%***
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
** Annual data of NOPAT and Invested Capital was used to calculate 3-Year ROIIC %.
*** Please be aware that the ROIIC (Return on Invested Capital) calculations are based on company-level data using the primary share class. The calculated data provided is for demonstration purposes and may slightly differ from the results displayed in the title due to potential variations caused by currency exchange rate differences throughout the year.
Singular Health Group (ASX:SHG) has a 3-Year ROIIC % of 165.02 as of Jun. 2025. 3-Year ROIIC % measures the change in earnings as a percentage of change in investment over 3-year. View historical data on Singular Health Group and its competitors. This is 18% above median its historical median of 139.45. Over the past decade, Singular Health Group's 3-Year ROIIC % has ranged from 113.88 to 165.02. According to the industry distribution chart, Singular Health Group ranks #47 out of 620 companies in the Healthcare Providers & Services industry, placing it in the top 7.6%.
Is Singular Health Group's 3-Year ROIIC % too high?
Singular Health Group's current 3-Year ROIIC % of 165.02 is 18% above median its 10-year median of 139.45. Over the past 10 years, this metric has ranged from a low of 113.88 to a high of 165.02. The Healthcare Providers & Services industry median 3-Year ROIIC % is 3.28. Singular Health Group's value of 165.02 is 4931.1% above this industry median. Based on the distribution chart, Singular Health Group ranks #47 out of 620 companies in the Healthcare Providers & Services industry, which is in the top quartile — a strong position relative to peers. Overall, Singular Health Group has a GF Score™ of 30/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Singular Health Group's 3-Year ROIIC % compare to VEEV and BTSG?
According to the Healthcare Providers & Services industry distribution chart, Singular Health Group ranks #47 out of 620 companies for 3-Year ROIIC %. This places Singular Health Group in the top 8% of its industry — outperforming the majority of peers. The industry median 3-Year ROIIC % is 3.28. Singular Health Group's value of 165.02 is 4931.1% above this benchmark. Historically, Singular Health Group's own 3-Year ROIIC % has ranged from 113.88 to 165.02 over the past decade. While the company's 10-year median is 139.45 vs. the industry median of 3.28, Singular Health Group has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-Year ROIIC % for a Healthcare Providers & Services company?
The median 3-Year ROIIC % among Healthcare Providers & Services companies is 3.28, based on 620 companies in the industry. Companies in the top quartile (top 25%) have a 3-Year ROIIC % significantly above this median, while those in the bottom quartile fall well below. However, 3-Year ROIIC % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Singular Health Group's current 3-Year ROIIC % of 165.02 is 4931.1% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-Year ROIIC % mean?
A high 3-Year ROIIC % can signal that a stock is expensive relative to its fundamentals. 3-Year ROIIC % measures the change in earnings as a percentage of change in investment over 3-year. View historical data on Singular Health Group and its competitors. For the Healthcare Providers & Services industry, the median 3-Year ROIIC % is 3.28 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Singular Health Group's current 3-Year ROIIC % is 165.02, which is 18% above median its own 10-year median of 139.45. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Singular Health Group stock overvalued right now?
Based on GuruFocus' analysis, Singular Health Group (ASX:SHG) is currently considered Significantly Overvalued. The stock's GF Value™ is A$0.11, compared to a current price of A$0.21 — trading 90.9% above its estimated fair value. The current 3-Year ROIIC % is 165.02, which is 18% above median its 10-year median of 139.45 and 4931.1% above the Healthcare Providers & Services industry median of 3.28. Singular Health Group's overall GF Score™ is 30/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-Year ROIIC % calculated?
3-Year ROIIC % is calculated from a company's financial statements. For Singular Health Group (ASX:SHG), the current 3-Year ROIIC % is 165.02 as of Jun. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Singular Health Group (ASX:SHG) Overvalued in 2026?
Based on GuruFocus' analysis, Singular Health Group stock appears to be overvalued.
The current stock price of A$0.21 is trading 90.9% above its estimated GF Value™ of A$0.11.
GuruFocus considers Singular Health Group to be Significantly Overvalued.
Key valuation signals for ASX:SHG:
3-Year ROIIC %: 165.02 (18% above median its 10-year median of 139.45)
GF Value™: A$0.11 vs. price of A$0.21 (90.9% above fair value)
Industry Position: 4931.1% above the Healthcare Providers & Services median (#47 of 620)
No single metric tells the full story. See the ASX:SHG stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Singular Health Group Ltd provides medical software solutions. The company's business segment is the provision of Volume Rendering Platform (VRP) software, providing 3D printing services and 3D machine sales. It operates in one segment, which is the provision and development of medical technology within Australia.
30GF Score
Get the complete analysis for ASX:SHG
3-Year ROIIC % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ASX:SHG has been successfully added to your 
